This article explores the critical challenge of balancing computational cost and predictive accuracy in contemporary drug discovery.
This article provides a comprehensive guide for researchers and drug development professionals on addressing the pervasive challenge of false positives in structure-based virtual screening.
Cryptic binding sites, transient pockets absent in ligand-free protein structures but present in ligand-bound forms, represent a promising frontier for targeting 'undruggable' proteins.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing compound libraries to enhance the efficiency of hit discovery.
The limited availability of high-quality structural data has long been a critical bottleneck in drug discovery.
Macrocycles are promising therapeutic candidates capable of targeting traditionally undruggable interfaces, but their rational design is hampered by significant conformational sampling challenges.
Molecular docking, a cornerstone of structure-based drug design, has long been hampered by the challenge of protein flexibility.
This article provides a comprehensive overview of the critical role molecular dynamics (MD) simulations play in the analysis of protein-ligand binding sites for modern drug discovery.
This article provides a comprehensive overview of combined ligand-based (LB) and structure-based (SB) virtual screening (VS) workflows, a cornerstone of modern computational drug discovery.
This article provides a comprehensive overview of scaffold hopping through ligand-based design, a pivotal strategy in medicinal chemistry for discovering novel chemical entities with retained bioactivity.